IUHSA
RCUS icon

Itau Unibanco Holding S.A.’s Arcus Biosciences RCUS Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-464
Closed -$4K – 961
2019
Q3 		$4K Hold
464
– – ﹤0.01% 295
2019
Q2 		$4K Sell
464
-371
-44% -$3.71K ﹤0.01% 599
2019
Q1 		$9K Hold
835
– – ﹤0.01% 575
2018
Q4 		$9K Sell
835
-116
-12% -$1.35K ﹤0.01% 575
2018
Q3 		$13K Sell
951
-34
-3% -$434 ﹤0.01% 576
2018
Q2 		$12K Buy
985
+601
+157% +$9.43K ﹤0.01% 695
2018
Q1 		$6K Buy
+384
New +$6.4K ﹤0.01% 564

Other funds holding RCUS

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Itau Unibanco Holding S.A.'s RCUS Position: Q4 2019 in Review

Itau Unibanco Holding S.A. sold out of Arcus Biosciences (RCUS) in Q4 2019, closing a stake of 464 shares — an estimated $4K sold.

Itau Unibanco Holding S.A. first reported a position in RCUS in Q1 2018 and held it in 7 quarters. The position peaked at $13K in Q3 2018. 75 funds tracked by Wall St. Rank hold RCUS as of Q4 2019.

  • Itau Unibanco Holding S.A. reported no remaining Arcus Biosciences position as of Q4 2019 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 464 Arcus Biosciences shares in Q4 2019, an estimated $4K.
  • Itau Unibanco Holding S.A. first reported a position in Arcus Biosciences in Q1 2018 and held it in 7 quarters.
  • Itau Unibanco Holding S.A.'s Arcus Biosciences position peaked at $13K in Q3 2018.
  • 75 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2019.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2019, filed 14 Feb 2020.